Connect with us

Hi, what are you looking for?

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

You May Also Like

World News

A French court on Friday convicted six teenagers in connection with the 2020 beheading of history teacher Samuel Paty, whose murder shocked the country....

Tech & Science

Consumer rights group Which? is suing Apple for £3bn over the way it deploys the iCloud. If the lawsuit succeeds, around 40 million Apple...

Business

Yum Brands on Tuesday reported quarterly earnings and revenue that missed Wall Street’s expectation as same-store sales at KFC and Pizza Hut slid more than expected. “The...

World News

The photos are happy occasions. A dad with two kids on holiday. Family pets with tails wagging. Teen daughters posing for selfies. This is...